Table 1.
Baseline cohort characteristics
Study | Location | Number | Eligible age range | Study period | OST uptake | SIF present | Homeless in the past 6 months (%) | Incarceration | HIV+ in sample (%) | Female (%) |
---|---|---|---|---|---|---|---|---|---|---|
Proyecto El Cuete IV | Tijuana, Mexico | 750 | 18+ | 2010–2020 | 28 % ever | No | 20 | 71 % ever | 5 | 38 |
STAHR II | San Diego, USA | 575 | 18+ | 2012–2016 | 23 % ever | No | 55 | 78 % ever | 10 | 26 |
V-DUSa | Vancouver, Canada | 1735 | 18+ | 1996–2020 | 53 % ever | Yes | 5 | 19 % ever | 0d | 31 |
COSINUSb | Paris, Marseille, Bordeaux, and Strasbourg, France | 680 | 18+ | 2016–2018 | – | Yesc | – | – | – | – |
aRefers to current VIDUS II sample (set to merge into V-DUS in 2016)
bData collection to begin in Fall 2016
cSIF likely to be implemented in Paris and Strasbourg in Fall 2016
dAll VIDUS II participants are HIV-negative at baseline